U.S. Tax Overhaul Makes Biotech Players Hungry For Big Deals | RSS News Feed

U.S. Tax Overhaul Makes Biotech Players Hungry For Big Deals - Latest News

RSS Feed for this news: U.S. Tax Overhaul Makes Biotech Players Hungry For Big Deals

Big Pharma CEOs Speak About Impact of Tax Reform on M&A

Quite a few pharmaceutical industry mergers – including some large deals - may be in the cards in 2018 now that the tax reforms are in place. The tax bill was signed into law by U.S. President ... As it is, major drug/biotech players struggling with ... read more

Drugmaker Shire soars as Japan's Takeda considers bid

“Takeda publicly saying it is considering an approach for Shire inevitably means that other big pharma players ... biotech group TiGenix NV (G9U.BR) for 520 million euros, funding the deal with cash on hand, and last year, it bought U.S. cancer drug ... read more

Bio-Techne (TECH) Q4 2017 Results - Earnings Call Transcript

Our Biotech division grew 2% organically in Q4 and finished the full year with 4% organic growth. This division was most impacted by the end market issues in both academia and Biopharma in the U.S. that ... the other big automation players, and we do ... read more

Looking for another news?


Corporate behemoths Amazon, Chase to create health insurance provider for their employees

“Those are three big players, and I think if they get into health care insurance or the health care coverage space they are going to make a big impact ... programs like Medicare after the overhaul of the tax law, to the uncertain future of the ... read more

Drugmaker Shire soars as Japan's Takeda considers bid

"Takeda publicly saying it is considering an approach for Shire inevitably means that other big pharma players ... buy Belgian biotech group TiGenix NV for 520 million euros, funding the deal with cash on hand, and last year, it bought U.S. cancer drug ... read more

Drugmaker Shire Soars as Japan's Takeda Considers Bid

"Takeda publicly saying it is considering an approach for Shire inevitably means that other big pharma players ... buy Belgian biotech group TiGenix NV for 520 million euros, funding the deal with cash on hand, and last year, it bought U.S. cancer drug ... read more

Drugmaker Shire soars as Japan's Takeda considers bid

“Takeda publicly saying it is considering an approach for Shire inevitably means that other big pharma players ... biotech group TiGenix NV (G9U.BR) for 520 million euros, funding the deal with cash on hand, and last year, it bought U.S. cancer drug ... read more

Big Pharma CEOs Speak About Impact of Tax Reform on M&A

Quite a few pharmaceutical industry mergers – including some large deals - may be in the cards in 2018 now that the tax reforms are in place. The tax bill was signed into law by U.S. President ... As it is, major drug/biotech players struggling with ... read more

UPDATE 5-Drugmaker Shire soars as Japan's Takeda considers bid

“Takeda publicly saying it is considering an approach for Shire inevitably means that other big pharma players ... buy Belgian biotech group TiGenix NV for 520 million euros, funding the deal with cash on hand, and last year, it bought U.S. cancer ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us